This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jun;8(7):763-6.

doi: 10.2217/imt-2016-0064.

Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?

Andrew Js Furness^{1

2}, Sergio A Quezada¹, Karl S Peggs¹

Affiliations

Affiliations

¹ Cancer Immunology Unit, University College London Cancer Institute, London, UK.
² The Royal Marsden NHS Foundation Trust, London, UK.

PMID: 27349975
DOI: 10.2217/imt-2016-0064

Editorial

Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?

Andrew Js Furness et al. Immunotherapy. 2016 Jun.

. 2016 Jun;8(7):763-6.

doi: 10.2217/imt-2016-0064.

Authors

Andrew Js Furness^{1

2}, Sergio A Quezada¹, Karl S Peggs¹

Affiliations

¹ Cancer Immunology Unit, University College London Cancer Institute, London, UK.
² The Royal Marsden NHS Foundation Trust, London, UK.

PMID: 27349975
DOI: 10.2217/imt-2016-0064

No abstract available

Keywords: CTLA-4; PD-1; heterogeneity; neoantigens.

PubMed Disclaimer

Similar articles

Introduction: Cancer Immunology Special Issue-Immunotherapy.
Kawakami Y. Kawakami Y. Int Immunol. 2016 Jul;28(7):317. doi: 10.1093/intimm/dxw028. Epub 2016 Jun 15. Int Immunol. 2016. PMID: 27313100 No abstract available.
The present status and future prospects of peptide-based cancer vaccines.
Hirayama M, Nishimura Y. Hirayama M, et al. Int Immunol. 2016 Jul;28(7):319-28. doi: 10.1093/intimm/dxw027. Epub 2016 May 28. Int Immunol. 2016. PMID: 27235694 Review.
The role of neoantigens in response to immune checkpoint blockade.
Riaz N, Morris L, Havel JJ, Makarov V, Desrichard A, Chan TA. Riaz N, et al. Int Immunol. 2016 Aug;28(8):411-9. doi: 10.1093/intimm/dxw019. Epub 2016 Apr 5. Int Immunol. 2016. PMID: 27048318 Free PMC article. Review.
Coinhibitory Pathways in Immunotherapy for Cancer.
Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH. Baumeister SH, et al. Annu Rev Immunol. 2016 May 20;34:539-73. doi: 10.1146/annurev-immunol-032414-112049. Epub 2016 Feb 25. Annu Rev Immunol. 2016. PMID: 26927206 Review.
Tumor Heterogeneity and Tumor Immunity: A Chicken-and-Egg Problem.
Spranger S. Spranger S. Trends Immunol. 2016 Jun;37(6):349-351. doi: 10.1016/j.it.2016.04.008. Epub 2016 May 8. Trends Immunol. 2016. PMID: 27166403

See all similar articles

Cited by

Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms.
Song W, Das M, Chen X. Song W, et al. Trends Cancer. 2020 Apr;6(4):288-298. doi: 10.1016/j.trecan.2020.01.011. Epub 2020 Feb 13. Trends Cancer. 2020. PMID: 32209444 Free PMC article. Review.
Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies.
Filipovic A, Miller G, Bolen J. Filipovic A, et al. Front Cell Dev Biol. 2020 Mar 17;8:155. doi: 10.3389/fcell.2020.00155. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32258034 Free PMC article. Review.
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives.
Lopes A, Vandermeulen G, Préat V. Lopes A, et al. J Exp Clin Cancer Res. 2019 Apr 5;38(1):146. doi: 10.1186/s13046-019-1154-7. J Exp Clin Cancer Res. 2019. PMID: 30953535 Free PMC article. Review.
The role of neoantigen in immune checkpoint blockade therapy.
Yi M, Qin S, Zhao W, Yu S, Chu Q, Wu K. Yi M, et al. Exp Hematol Oncol. 2018 Nov 16;7:28. doi: 10.1186/s40164-018-0120-y. eCollection 2018. Exp Hematol Oncol. 2018. PMID: 30473928 Free PMC article. Review.
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.
Wang DR, Wu XL, Sun YL. Wang DR, et al. Signal Transduct Target Ther. 2022 Sep 19;7(1):331. doi: 10.1038/s41392-022-01136-2. Signal Transduct Target Ther. 2022. PMID: 36123348 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations